These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

539 related articles for article (PubMed ID: 27106296)

  • 61. The effects of antipsychotic discontinuation or maintenance on the process of recovery in remitted first-episode psychosis patients - A systematic review and meta-analysis of randomized controlled trials.
    Béchard L; Desmeules C; Bachand L; Huot-Lavoie M; Corbeil O; Anderson E; Brodeur S; LeBlanc A; Demers MF; Lauzier S; Roy MA
    Eur Psychiatry; 2024 Jan; 67(1):e13. PubMed ID: 38250810
    [TBL] [Abstract][Full Text] [Related]  

  • 62. An observational study of antipsychotic medication discontinuation in first-episode psychosis: clinical and functional outcomes.
    Malla A; Iyer SN; Joober R; Rangaswamy T; Ramachandran P; Schmitz N; Taksal A; Mohan G; Margolese HC
    Soc Psychiatry Psychiatr Epidemiol; 2022 Jul; 57(7):1329-1340. PubMed ID: 35041015
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Predictors of discontinuation of antipsychotic medication and subsequent outcomes in the European First Episode Schizophrenia Trial (EUFEST).
    Landolt K; Rössler W; Ajdacic-Gross V; Derks EM; Libiger J; Kahn RS; Fleischhacker WW;
    Schizophr Res; 2016 Apr; 172(1-3):145-51. PubMed ID: 26922655
    [TBL] [Abstract][Full Text] [Related]  

  • 64. [Psychopharmacology of First Episode Psychosis: An Approach Based on Recovery].
    Béchard L; Corbeil O; Malenfant E; Lehoux C; Stip E; Roy MA; Demers MF
    Sante Ment Que; 2021; 46(2):113-137. PubMed ID: 35617496
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Reprint of: Negative symptoms predict high relapse rates and both predict less favorable functional outcome in first episode psychosis, independent of treatment strategy.
    Wunderink L; van Bebber J; Sytema S; Boonstra N; Meijer RR; Wigman JTW
    Schizophr Res; 2020 Nov; 225():69-76. PubMed ID: 33279373
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Antipsychotic prophylaxis is needed after remission from a first psychotic episode in schizophrenia patients: results from an aborted randomised trial.
    Boonstra G; Burger H; Grobbee DE; Kahn RS
    Int J Psychiatry Clin Pract; 2011 Jun; 15(2):128-34. PubMed ID: 22121861
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Maintenance treatment for patients with a first psychotic episode.
    Sommer IEC; Oomen PP; Hasan A
    Curr Opin Psychiatry; 2019 May; 32(3):147-156. PubMed ID: 30720486
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Visual working memory deterioration preceding relapse in psychosis.
    Hui CL; Li YK; Li AW; Lee EH; Chang WC; Chan SK; Lam SY; Thornton AE; Sham P; Honer WG; Chen EY
    Psychol Med; 2016 Aug; 46(11):2435-44. PubMed ID: 27305830
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Dose Reduction/Discontinuation of Antipsychotic Drugs in Psychosis; Effect on Cognition and Functional Outcomes.
    Omachi Y; Sumiyoshi T
    Front Psychiatry; 2018; 9():447. PubMed ID: 30294286
    [No Abstract]   [Full Text] [Related]  

  • 70. Allostatic load is associated with psychotic symptoms and decreases with antipsychotic treatment in patients with schizophrenia and first-episode psychosis.
    Berger M; Juster RP; Westphal S; Amminger GP; Bogerts B; Schiltz K; Bahn S; Steiner J; Sarnyai Z
    Psychoneuroendocrinology; 2018 Apr; 90():35-42. PubMed ID: 29427955
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Three-Year Naturalistic Study On Early Use Of Long-Acting Injectable Antipsychotics In First Episode Psychosis.
    Medrano S; Abdel-Baki A; Stip E; Potvin S
    Psychopharmacol Bull; 2018 Jun; 48(4):25-61. PubMed ID: 30618474
    [TBL] [Abstract][Full Text] [Related]  

  • 72. The expert consensus guideline series. Optimizing pharmacologic treatment of psychotic disorders. Introduction: methods, commentary, and summary.
    Kane JM; Leucht S; Carpenter D; Docherty JP;
    J Clin Psychiatry; 2003; 64 Suppl 12():5-19. PubMed ID: 14640142
    [TBL] [Abstract][Full Text] [Related]  

  • 73. A cross-sectional observational study of healthcare professional views of factors affecting teenage adherence with antipsychotic medication.
    Ramdour S; Duxbury JA; Becket G; Wilson S
    J Psychiatr Ment Health Nurs; 2015 Sep; 22(7):491-501. PubMed ID: 25990303
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Antipsychotic medication and remission of psychotic symptoms 10years after a first-episode psychosis.
    Wils RS; Gotfredsen DR; Hjorthøj C; Austin SF; Albert N; Secher RG; Thorup AA; Mors O; Nordentoft M
    Schizophr Res; 2017 Apr; 182():42-48. PubMed ID: 28277310
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Long-Acting Injectable Risperidone for Relapse Prevention and Control of Breakthrough Symptoms After a Recent First Episode of Schizophrenia. A Randomized Clinical Trial.
    Subotnik KL; Casaus LR; Ventura J; Luo JS; Hellemann GS; Gretchen-Doorly D; Marder S; Nuechterlein KH
    JAMA Psychiatry; 2015 Aug; 72(8):822-9. PubMed ID: 26107752
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Risk Factors for Psychotic Relapse After Dose Reduction or Discontinuation of Antipsychotics in Patients With Chronic Schizophrenia. A Meta-Analysis of Randomized Controlled Trials.
    Bogers JPAM; Hambarian G; Walburgh Schmidt N; Vermeulen JM; de Haan L
    Schizophr Bull; 2023 Jan; 49(1):11-23. PubMed ID: 36200866
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Ethyl-eicosapentaenoic acid in first-episode psychosis: a randomized, placebo-controlled trial.
    Berger GE; Proffitt TM; McConchie M; Yuen H; Wood SJ; Amminger GP; Brewer W; McGorry PD
    J Clin Psychiatry; 2007 Dec; 68(12):1867-75. PubMed ID: 18162017
    [TBL] [Abstract][Full Text] [Related]  

  • 78. [Atypical antipsychotics in first-episode psychosis: a review].
    Rotgé JY; Aouizerate B; Tignol J
    Encephale; 2008 Apr; 34(2):194-204. PubMed ID: 18597729
    [TBL] [Abstract][Full Text] [Related]  

  • 79. Tapered discontinuation vs. maintenance therapy of antipsychotic medication in patients with first-episode schizophrenia: Obstacles, findings, and lessons learned in the terminated randomized clinical trial TAILOR.
    Stürup AE; Hjorthøj C; Albert N; Dolmer S; Birk M; Ebdrup BH; Eplov LF; Jensen H; Vernal DL; Speyer H; Mors O; Nordentoft M
    Front Psychiatry; 2022; 13():910703. PubMed ID: 35935409
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Dopamine dysregulation in psychotic relapse after antipsychotic discontinuation: an [
    Kim S; Shin SH; Santangelo B; Veronese M; Kang SK; Lee JS; Cheon GJ; Lee W; Kwon JS; Howes OD; Kim E
    Mol Psychiatry; 2021 Jul; 26(7):3476-3488. PubMed ID: 32929214
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.